Accurate proteome-wide missense variant effect prediction with AlphaMissense

Jun Cheng(Google DeepMind (United Kingdom)), Guido Novati(Google DeepMind (United Kingdom)), Joshua Pan(Google DeepMind (United Kingdom)), Clare Bycroft(Google DeepMind (United Kingdom)), Akvilė Žemgulytė(Google DeepMind (United Kingdom)), Taylor Applebaum(Google DeepMind (United Kingdom)), Alexander Pritzel(Google DeepMind (United Kingdom)), Lai Hong Wong(Google DeepMind (United Kingdom)), Michal Zielinski(Google DeepMind (United Kingdom)), Tobias Sargeant(Google DeepMind (United Kingdom)), Rosalia G. Schneider(Google DeepMind (United Kingdom)), Andrew Senior(Google DeepMind (United Kingdom)), John Jumper(Google DeepMind (United Kingdom)), Demis Hassabis(Google DeepMind (United Kingdom)), Pushmeet Kohli(Google DeepMind (United Kingdom)), Žiga Avsec(Google DeepMind (United Kingdom))
Science
September 19, 2023
Cited by 1,970

Abstract

The vast majority of missense variants observed in the human genome are of unknown clinical significance. We present AlphaMissense, an adaptation of AlphaFold fine-tuned on human and primate variant population frequency databases to predict missense variant pathogenicity. By combining structural context and evolutionary conservation, our model achieves state-of-the-art results across a wide range of genetic and experimental benchmarks, all without explicitly training on such data. The average pathogenicity score of genes is also predictive for their cell essentiality, capable of identifying short essential genes that existing statistical approaches are underpowered to detect. As a resource to the community, we provide a database of predictions for all possible human single amino acid substitutions and classify 89% of missense variants as either likely benign or likely pathogenic.


Related Papers